A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2003

Primary Completion Date

April 30, 2006

Conditions
Chronic Hepatitis B
Interventions
DRUG

telbivudine or lamivudine

Trial Locations (11)

Unknown

Los Angeles

Orange

San Diego

Hackensack

Houston

Seoul

Barcelona

Valencia

Bangkok

Istanbul

London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Novartis

INDUSTRY